Use of a Long-Acting Opioid Microsphere Formulation to Overcome Difficulties in Swallowing Pain Medication

PURPOSE: Xtampza ER(®) (XER) is a long-acting oxycodone formulation which was designed to be abuse-deterrent and to overcome capsule-swallowing issues. This pilot study evaluated the effectiveness of XER at reducing swallowing difficulty while providing effective analgesia in the setting of chronic...

Descripción completa

Detalles Bibliográficos
Autores principales: Anderson, Nathan, Gillman, Andrea G, Wasan, Ajay D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7212775/
https://www.ncbi.nlm.nih.gov/pubmed/32440201
http://dx.doi.org/10.2147/JPR.S249592

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7212775/
https://www.ncbi.nlm.nih.gov/pubmed/32440201
http://dx.doi.org/10.2147/JPR.S249592

Ejemplares similares